PRSS1 and breast cancer: In this study, we used the CRISPR/CAS9-mediated mutation of T29I substitution in the endogenous copy of the Prss1 gene allele in a mouse BC model, suggesting that T29I was a proper counterpart of human Prss1N29I mutation.